Webinars on this topic
2016 ESC webinar "Multidisciplinary Heart Team Discussion : how to manage a patient with dyspnea" Watch the recording.
2015 ESC webinar on "Diagnostic and therapeutic dilemmas in patients with acute pulmonary embolism: What is new in the 2014 ESC Guidelines?" Watch the recording.
2015 ESC webinar on "Acute Pulmonary Embolism" Watch the recording.
Update - ESC Congress 2015 sessions
Topics in focus
| Session Title |
Slides |
Webcast |
| Optimal management of pulmonary embolism |
|
|
| Does this patient have a pulmonary embolism? |
|
|
| Does this patient have a pulmonary embolism? Panel discussion and questions from the audience. |
|
|
| A patient with recurrent pulmonary embolism. |
|
|
| A patient with recurrent pulmonary embolism - Panel discussion and questions from the audience. |
|
|
| Systems of care: ideal management of pulmonary embolism - From emergency room to discharge - State of the art lecture. |
|
|
| Acute pulmonary embolism - When Guidelines do not help |
|
|
| Subsegmental pulmonary embolism. |
|
|
| Deep venous thrombosis in patients with pulmonary embolism. |
|
|
| Pulmonary embolism in pregnancy. |
|
|
| Indefinite anticoagulation: who are the candidates? |
|
|
| Acute pulmonary embolism: persisting and new controversies |
|
|
| Echocardiography and biomarker testing are mandatory in normotensive patients. PRO. |
|
|
| Echocardiography and biomarker testing are mandatory in normotensive patients. CONTRA. |
|
|
| Echocardiography and biomarker testing are mandatory in normotensive patients - CONCLUSION |
|
|
| Acute pulmonary embolism: persisting and new controversies |
|
|
| New oral anticoagulants are the new standard of care. CONTRA. |
|
|
| New oral anticoagulants are the new standard of care - CONCLUSION |
|
|
| Risk stratification in pulmonary embolism and in pulmonary hypertension |
|
|
| BNP testing performed after triaging patients with acute PE by standard Hestia decision rule is not needed - a randomised trial |
|
|
| Effectiveness of a clinical score, cardiac troponin, and echocardiography testing algorithm for risk stratification of normotensive patients with acute symptomatic pulmonary embolism |
|
|
| Risk stratification in pulmonary embolism and in pulmonary hypertension - rapid fire abstracts |
|
|
| Prognostic impact of cardiovascular risk in pulmonary embolism. |
|
|
| Patient selection in outpatient and short-stay treatment in pulmonary embolism - comparison of different criteria (PESI, sPESI, Hestia and RVD on CT) in relation to ESC 2014 guidelines |
|
|
| Comparisson of rivaroxaban and vitamin K antagonists anticoagulant therapy after thrombolysis in patients with intermediate and high risk pulmonary embolism |
|
|
| Identification of normotensive patients with pulmonary embolism at high risk of adverse clinical outcome: comparison of two clinical scores |
|
|
ESC Congress 2014 Sessions
Part 1 - Overview of the ESC Guidelines on Pulmonary Embolism
| Topic |
Session |
Slides |
Webcast |
Pumonary embolism
|
Pulmonary embolism. |
|
|
| Pulmonary embolism. |
|
| Pulmonary embolism: what do the Guidelines say. |
|
|
| ESC Guidelines on pulmonary embolism. What is new? What has changed? |
Diagnostic approach: prediction rules, imaging procedures and algorithms. |
|
|
| Treatment modalities: anticoagulation, thrombolysis, interventions. |
|
|
Risk-adjusted
therapeutic strategies. |
|
|
Part 2 - Topics in Focus
| Topic |
Session |
Slides |
Webcast |
| Acute Pulmonary Embolism |
New interventional and surgical procedures in pulmonary vascular diseases |
|
|
The 2014 ESC Guidelines for pulmonary embolism: hot topics
|
A patient with dyspnoea and dizziness. |
|
|
| Dyspnoea and dizziness: what do the Guidelines say. |
|
|
| Chest pain, dyspnoea and positive biomarkers: what do the Guidelines say. |
|
|
| A pregnant woman with acute dyspnoea. |
|
|
| Pregnancy and acute dyspnoea: what do the Guidelines say. |
|
|
| Randomised controlled trials and meta-analyses in pulmonary vascular disease |
Thrombolysis for intermediate-risk pulmonary embolism: 6-month follow-up of the PEITHO trial |
|
|
Poster session 1: New aspects in acute pulmonary embolism |
Clinical presentation and outcome in patients with pulmonary embolism with and without cancer |
|
|
New insights in acute pulmonary embolism |
Meta-analysis of impending paradoxical embolism |
|
|
| Optimized high sensitive troponin T cut-off values for risk stratification of normotensive patients with pulmonary embolism |
|
|
| Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism |
|
|
| Use of a diagnostic computerized clinical decision support and outcomes of suspected pulmonary embolism |
|
|
| Poster session 2: Acute pulmonary embolism and basic science in pulmonary arterial hypertension |
Local fibrinolysis, rotational thrombus fragmentation and thrombus aspiration in patients with massive pulmonary embolism |
|
|
| Chronic pulmonary hypertension |
External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism |
|
|
| Imaging in myocardial disease and thromboembolic pulmonary hypertension |
Either balloon pulmonary angioplasty or surgical pulmonary endarterectomy can cover most of patients with chronic thromboembolic pulmonary hypertension as treatment option |
|
|
| New interventional and surgical procedures in pulmonary vascular diseases |
Chronic thromboembolic pulmonary hypertension: the role of percutaneous pulmonary angioplasty. |
|
|
| Chronic pulmonary hypertension |
What happens after acute PE? Insights into the transition to CTEPH. |
|
|
Our mission: To reduce the burden of cardiovascular disease.